Jannuzzı, A. T. Et Al. 2023. Molecular Cardiotoxic Effects of Proteasome Inhibitors Carfilzomib and Ixazomib and Their Combination with Dexamethasone Involve Mitochondrial Dysregulation. Cardiovascular Toxicology , vol.23, no.3-4 , 121-131.

Jannuzzı, A. T., Korkmaz, N. S., Günaydın Akyıldız, A., Arslan Eseryel, S., Karademir Yilmaz, B., & Alpertunga, B., (2023). Molecular Cardiotoxic Effects of Proteasome Inhibitors Carfilzomib and Ixazomib and Their Combination with Dexamethasone Involve Mitochondrial Dysregulation. Cardiovascular Toxicology , vol.23, no.3-4, 121-131.

Jannuzzı, Ayşe Et Al. "Molecular Cardiotoxic Effects of Proteasome Inhibitors Carfilzomib and Ixazomib and Their Combination with Dexamethasone Involve Mitochondrial Dysregulation," Cardiovascular Toxicology , vol.23, no.3-4, 121-131, 2023

Jannuzzı, Ayşe T. Et Al. "Molecular Cardiotoxic Effects of Proteasome Inhibitors Carfilzomib and Ixazomib and Their Combination with Dexamethasone Involve Mitochondrial Dysregulation." Cardiovascular Toxicology , vol.23, no.3-4, pp.121-131, 2023

Jannuzzı, A. T. Et Al. (2023) . "Molecular Cardiotoxic Effects of Proteasome Inhibitors Carfilzomib and Ixazomib and Their Combination with Dexamethasone Involve Mitochondrial Dysregulation." Cardiovascular Toxicology , vol.23, no.3-4, pp.121-131.

@article{article, author={Ayşe Tarbın JANNUZZI Et Al. }, title={Molecular Cardiotoxic Effects of Proteasome Inhibitors Carfilzomib and Ixazomib and Their Combination with Dexamethasone Involve Mitochondrial Dysregulation}, journal={Cardiovascular Toxicology}, year=2023, pages={121-131} }